The World Tobacco Industry

Tobacco crop is cultivated in over 100 countries. China is considered the world’s major manufacturer. Other main providers are the United States, India, Brazil, Turkey, Zimbabwe and Malawi. Smoking products are used worldwide. The majority of tobacco is used for smoking; it is the fundamental component for cigarettes, pipes, cigars, roll-your-own, and bidis. Tobacco is also utilized for smokeless tobacco such as snuff or chewing tobacco. More than 80 % of world tobacco is widely used for cigarettes.
Among cigarettes, the global share of the American blend (a blend of Virginia, Burley and Oriental tobacco types) is boosting, and that for dark cigarettes is falling. China owns about 30 % of the whole production and consumption of cigarettes. At 12 % of the overall, the United States is the world’s second biggest maker. Some other major producers are Japan, Indonesia, Brazil and Germany. The global demand for tobacco products in the more developed countries is currently dropping. In the less emerging countries its expansion has slowed up. The international cigarette market is getting more and more concentrated by company. The three greatest corporations sell about 2/3 of the world’s total. In separate countries, the level of concentration can be higher. The cigarette manufacturers have responded to the sluggishness of demand in their conventional markets in three approaches: consolidation, variation, and increasing productivity. Government authorities deal with a dilemma. They currently have both an economic and a social interest in tobacco crop. It offers work opportunities, tax earnings and in particular cases foreign exchange profits. However governments also have a responsibility to guard their population’s health. Curing people from smoking-related diseases can be quite expensive. Generally, authorities deal with these disagreeing difficulties by discouraging demand in a number of ways. Increasing cigarette tax is the most popular method. Various have sued the cigarette manufacturers trying to recuperate the price of treating people for smoking-related diseases.
Global works prospective in the tobacco handling industry are not positive. Consolidation, privatization, greater productivity and sluggish demand increase together have a dampening impact on employment prospects. Job opportunities in countries with excessive costs and decreasing demand look mainly insecure. But in an open world economy it is eventually up to the giant companies to determine where to focus production, and which market will be supplied from where.

Women Smoking Style

Tobacco use in Indiana

Tobacco use is also a well-known risk factor for heart disease, cancer, stroke, and diabetes. Using the BRFSS, questions included whether respondents were currently smoking. For all adults, the prevalence of smoking has decreased from 27.6% over the past seven years (2002 to 2009). For most age groups (excluding 18-24 and 65+), however [95% CI contains national median for 18-24 and 65+], smoking rates in Indiana remain higher than the national median.

YEAR % n =
2002 27.6 1533
2003 26.1 1391
2004 24.9 1529
2005 27.3 1416
2006 24.1 1442
2007 24.1 1359
2008 26.0 1108
2009 23.1 1943

Tobacco use - cause of illness

Tobacco use is the leading preventable cause of death and illness in the United States, causing more than 443 000 deaths each year. The consequences of tobacco use include harms to the health of the fetus, such as low birth weight and sudden infant death; harms to children from tobacco use and secondhand tobacco-smoke (SHS) exposure, including respiratory illness, infection, and decreased lung function; the uptake and establishment of tobacco use and nicotine addiction by the next generation; fires attributable to smoking; the economic costs of purchasing tobacco and tobacco-use materials; litter and debris from tobacco products; additional cleaning and maintenance of facilities in which tobacco is used; the health care and emotional costs of diseases associated with tobacco use and SHS exposure; and the costs to families and society because of poor health and lost productivity.

Most tobacco users (
80%) started using tobacco products before 18 years of age.Initiation of tobacco use is often instigated by exposure to tobacco use by parents or peers, depiction in movies and other media, advertising targeting children and adolescents, and other environmental and cultural factors. The connection between children and tobacco use is so strong that the commissioner of the US Food and Drug Administration declared tobacco use a “pediatric disease” in 1995.

Tobacco use is a pediatric disease because of the extent of harms to children caused by tobacco use and SHS exposure, the relationship of pediatric tobacco use and exposure to adult tobacco use, the existence of effective interventions to reduce tobacco use, and the documented underuse of those interventions. This statement provides guidance for providers of pediatric services, including the American Academy of Pediatrics (AAP) and its members, and summarizes other AAP policies that have addressed tobacco use and control. Because tobacco use has significant effects on children and families, its management has been reviewed in many AAP policies and official documents.

The information and recommendations described in this statement are consistent with recommendations in the other AAP publications cited as well as with tobacco policies from other clinical professional membership organizations, including the Academic Pediatric Association, the American Academy of Allergy Asthma & Immunology, the American Academy of Family Practice, 21 the American Academy of Pediatric Dentistry, and the American Medical Association. The policy is accompanied by 2 technical reports: “Secondhand and Prenatal Tobacco Smoke Exposure” and “Tobacco as a Substance of Abuse.”The AAP recognizes the dangers of tobacco use and SHS exposure to children’s health. Tobacco control was named a strategic priority by the AAP in 2005, and the Julius B. Richmond Center of Excellence (www.aap.org/ richmondcenter), dedicated to the elimination of children’s exposure to tobacco and SHS, was established in 2007 to foster tobacco-control initiatives at the AAP.

Policy Statement—Tobacco Use: A Pediatric Disease

Tobacco use is the leading preventable cause of death and illness in the United States, causing more than 443 000 deaths each year.
The consequences of tobacco use include harms to the health of the fetus, such as low birth weight and sudden infant death; harms to children from tobacco use and secondhand tobacco-smoke (SHS) exposure, including respiratory illness, infection, and decreased lung function; the uptake and establishment of tobacco use and nicotine addiction by the next generation; fires attributable to smoking; the economic costs of purchasing tobacco and tobacco-use maerials; litter and debris from tobacco products; additional cleaning and maintenance of facilities in which tobacco is used; the health care and emotional costs of diseases associated with tobacco use and SHS exposure; and the costs to families and society because of poor health and lost productivity.
Most tobacco users (80%) started using tobacco products before 18 years of age.
Initiation of tobacco use is often instigated by exposure to tobacco use by parents or peers, depiction in movies and other media, advertising targeting children and adolescents, and other environmental and cultural factors.3–12 The connection between children and tobacco use is so strong that the commissioner of the US Food and Drug Administration declared tobacco use a “pediatric disease” in 1995.
Tobacco use is a pediatric disease because of the extent of harms to children caused by tobacco use and SHS exposure, the relationship of pediatric tobacco use and exposure to adult tobacco use, the existence of effective interventions to reduce tobacco use,14 and the documented underuse of those interventions.15 This statement provides guidance for providers of pediatric services, including the American Academy of Pediatrics (AAP) and its members, and summarizes other AAP policies that have addressed tobacco use and control. Because tobacco use has significant effects on children and families, its management has been reviewed in many AAP policies and official documents.16–18 The information and recommendations described in this statement are consistent with recommendations in the other AAP publications cited as well as with tobacco policies from other clinical professional membership organizations, including the Academic Pediatric Association, the American Academy of Allergy Asthma & Immunology,20 the American Academy of Family Practice, the American Academy of Pediatric Dentistry,22 and the American Medical Association.
The policy is accompanied by 2 technical reports: “Secondhand and Prenatal Tobacco Smoke Exposure”and “Tobacco as a Substance of Abuse.”The AAP recognizes the dangers of tobacco use and SHS exposure to children’s health. Tobacco control was named a strategic priority by the AAP in 2005, and the Julius B. Richmond Center of Excellence (www.aap.org/ richmondcenter), dedicated to the elimination of children’s exposure to tobacco and SHS, was established in 2007 to foster tobacco-control initiatives at the AAP.